Use of middle hepatic vein in right lobe living donor liver transplantation

Murat Dayangac, C. Burcin Taner, Deniz Balci, Izzet Memi, Onur Yaprak, Baris Akin, Cihan Duran, Refik Killi, Omer Ayanoglu, Yildiray Yuzer, Yaman Tokat

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

The harvesting of the middle hepatic vein (MHV) with the right lobe graft for living-donor liver transplantation allows an optimal venous drainage for the recipient; however, it is an extensive operation for the donor. This is a prospective, nonrandomized study evaluating liver functions and early clinical outcome in donors undergoing right hepatectomy with or without MHV harvesting. From August 2005 to July 2007, a total of 100 donor right hepatectomies were performed with (n = 49) or without (n = 51) the inclusion of the MHV. The decision to take MHV was based on an algorithm that considers various donor and recipient factors. There was no donor mortality in donors in either group. Overall complication rate was higher in MHV (+) donor group, however when remnant liver volume was kept above 30%, complication rates were similar between the groups. The results of this study show that right hepatectomy including the MHV neither affects morbidity nor impairs early liver function in donors when remnant volume is kept above 30%. The decision, therefore, of the extent of right lobe donor hepatectomy should be tailored to the particular conditions considering the graft quality and metabolic demand of the recipient.

Original languageEnglish (US)
Pages (from-to)285-291
Number of pages7
JournalTransplant International
Volume23
Issue number3
DOIs
StatePublished - Mar 1 2010
Externally publishedYes

Fingerprint

Hepatic Veins
Living Donors
Liver Transplantation
Tissue Donors
Hepatectomy
Liver
Transplants
Drainage
Prospective Studies
Morbidity
Mortality

Keywords

  • Donor complications
  • Living donor liver transplantation
  • Middle hepatic vein

ASJC Scopus subject areas

  • Transplantation

Cite this

Dayangac, M., Taner, C. B., Balci, D., Memi, I., Yaprak, O., Akin, B., ... Tokat, Y. (2010). Use of middle hepatic vein in right lobe living donor liver transplantation. Transplant International, 23(3), 285-291. https://doi.org/10.1111/j.1432-2277.2009.00978.x

Use of middle hepatic vein in right lobe living donor liver transplantation. / Dayangac, Murat; Taner, C. Burcin; Balci, Deniz; Memi, Izzet; Yaprak, Onur; Akin, Baris; Duran, Cihan; Killi, Refik; Ayanoglu, Omer; Yuzer, Yildiray; Tokat, Yaman.

In: Transplant International, Vol. 23, No. 3, 01.03.2010, p. 285-291.

Research output: Contribution to journalArticle

Dayangac, M, Taner, CB, Balci, D, Memi, I, Yaprak, O, Akin, B, Duran, C, Killi, R, Ayanoglu, O, Yuzer, Y & Tokat, Y 2010, 'Use of middle hepatic vein in right lobe living donor liver transplantation', Transplant International, vol. 23, no. 3, pp. 285-291. https://doi.org/10.1111/j.1432-2277.2009.00978.x
Dayangac, Murat ; Taner, C. Burcin ; Balci, Deniz ; Memi, Izzet ; Yaprak, Onur ; Akin, Baris ; Duran, Cihan ; Killi, Refik ; Ayanoglu, Omer ; Yuzer, Yildiray ; Tokat, Yaman. / Use of middle hepatic vein in right lobe living donor liver transplantation. In: Transplant International. 2010 ; Vol. 23, No. 3. pp. 285-291.
@article{a66227963c284ab3b0e5206f0da49771,
title = "Use of middle hepatic vein in right lobe living donor liver transplantation",
abstract = "The harvesting of the middle hepatic vein (MHV) with the right lobe graft for living-donor liver transplantation allows an optimal venous drainage for the recipient; however, it is an extensive operation for the donor. This is a prospective, nonrandomized study evaluating liver functions and early clinical outcome in donors undergoing right hepatectomy with or without MHV harvesting. From August 2005 to July 2007, a total of 100 donor right hepatectomies were performed with (n = 49) or without (n = 51) the inclusion of the MHV. The decision to take MHV was based on an algorithm that considers various donor and recipient factors. There was no donor mortality in donors in either group. Overall complication rate was higher in MHV (+) donor group, however when remnant liver volume was kept above 30{\%}, complication rates were similar between the groups. The results of this study show that right hepatectomy including the MHV neither affects morbidity nor impairs early liver function in donors when remnant volume is kept above 30{\%}. The decision, therefore, of the extent of right lobe donor hepatectomy should be tailored to the particular conditions considering the graft quality and metabolic demand of the recipient.",
keywords = "Donor complications, Living donor liver transplantation, Middle hepatic vein",
author = "Murat Dayangac and Taner, {C. Burcin} and Deniz Balci and Izzet Memi and Onur Yaprak and Baris Akin and Cihan Duran and Refik Killi and Omer Ayanoglu and Yildiray Yuzer and Yaman Tokat",
year = "2010",
month = "3",
day = "1",
doi = "10.1111/j.1432-2277.2009.00978.x",
language = "English (US)",
volume = "23",
pages = "285--291",
journal = "Transplant International",
issn = "0934-0874",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Use of middle hepatic vein in right lobe living donor liver transplantation

AU - Dayangac, Murat

AU - Taner, C. Burcin

AU - Balci, Deniz

AU - Memi, Izzet

AU - Yaprak, Onur

AU - Akin, Baris

AU - Duran, Cihan

AU - Killi, Refik

AU - Ayanoglu, Omer

AU - Yuzer, Yildiray

AU - Tokat, Yaman

PY - 2010/3/1

Y1 - 2010/3/1

N2 - The harvesting of the middle hepatic vein (MHV) with the right lobe graft for living-donor liver transplantation allows an optimal venous drainage for the recipient; however, it is an extensive operation for the donor. This is a prospective, nonrandomized study evaluating liver functions and early clinical outcome in donors undergoing right hepatectomy with or without MHV harvesting. From August 2005 to July 2007, a total of 100 donor right hepatectomies were performed with (n = 49) or without (n = 51) the inclusion of the MHV. The decision to take MHV was based on an algorithm that considers various donor and recipient factors. There was no donor mortality in donors in either group. Overall complication rate was higher in MHV (+) donor group, however when remnant liver volume was kept above 30%, complication rates were similar between the groups. The results of this study show that right hepatectomy including the MHV neither affects morbidity nor impairs early liver function in donors when remnant volume is kept above 30%. The decision, therefore, of the extent of right lobe donor hepatectomy should be tailored to the particular conditions considering the graft quality and metabolic demand of the recipient.

AB - The harvesting of the middle hepatic vein (MHV) with the right lobe graft for living-donor liver transplantation allows an optimal venous drainage for the recipient; however, it is an extensive operation for the donor. This is a prospective, nonrandomized study evaluating liver functions and early clinical outcome in donors undergoing right hepatectomy with or without MHV harvesting. From August 2005 to July 2007, a total of 100 donor right hepatectomies were performed with (n = 49) or without (n = 51) the inclusion of the MHV. The decision to take MHV was based on an algorithm that considers various donor and recipient factors. There was no donor mortality in donors in either group. Overall complication rate was higher in MHV (+) donor group, however when remnant liver volume was kept above 30%, complication rates were similar between the groups. The results of this study show that right hepatectomy including the MHV neither affects morbidity nor impairs early liver function in donors when remnant volume is kept above 30%. The decision, therefore, of the extent of right lobe donor hepatectomy should be tailored to the particular conditions considering the graft quality and metabolic demand of the recipient.

KW - Donor complications

KW - Living donor liver transplantation

KW - Middle hepatic vein

UR - http://www.scopus.com/inward/record.url?scp=75149187909&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=75149187909&partnerID=8YFLogxK

U2 - 10.1111/j.1432-2277.2009.00978.x

DO - 10.1111/j.1432-2277.2009.00978.x

M3 - Article

C2 - 19821954

AN - SCOPUS:75149187909

VL - 23

SP - 285

EP - 291

JO - Transplant International

JF - Transplant International

SN - 0934-0874

IS - 3

ER -